品牌 | 货号 | 包装单位 | 货期 | CAS | 产品名称 | 质量规格 | 单价(¥) | 购买数量 |
---|---|---|---|---|---|---|---|---|
源叶 | S80577-500mg | 500mg | 厂家现货 | 264218-23-7 |
Acadesine Acadesine |
99% |
|
|
源叶 | S80579-10mg | 10mg | 厂家现货 | 264218-23-7 |
SB415286 SB415286 |
99% |
|
|
源叶 | S80579-50mg | 50mg | 厂家现货 | 264218-23-7 |
SB415286 SB415286 |
99% |
|
|
源叶 | S80579-2mg | 2mg | 厂家现货 | 264218-23-7 |
SB415286 SB415286 |
99% |
|
|
源叶 | S80579-5mg | 5mg | 厂家现货 | 264218-23-7 |
SB415286 SB415286 |
99% |
|
|
源叶 | S80579-25mg | 25mg | 厂家现货 | 264218-23-7 |
SB415286 SB415286 |
99% |
|
|
索莱宝 | YS123859-100mg | 100mg | 厂家现货 | 264218-23-7 |
3-((3-氯-4-羟基苯基)氨基)-4-(2-硝基苯基... 3-((3-Chloro-4-hydroxyphenyl... |
98% |
|
|
索莱宝 | YS123859-250mg | 250mg | 厂家现货 | 264218-23-7 |
3-((3-氯-4-羟基苯基)氨基)-4-(2-硝基苯基... 3-((3-Chloro-4-hydroxyphenyl... |
98% |
|
|
索莱宝 | YS123859-1g | 1g | 厂家现货 | 264218-23-7 |
3-((3-氯-4-羟基苯基)氨基)-4-(2-硝基苯基... 3-((3-Chloro-4-hydroxyphenyl... |
98% |
|
|
索莱宝 | YS123859-50mg | 50mg | 厂家现货 | 264218-23-7 |
3-((3-氯-4-羟基苯基)氨基)-4-(2-硝基苯基... 3-((3-Chloro-4-hydroxyphenyl... |
98% |
|
|
阿拉丁 | S129720-10mg | 10mg | 现货 | 264218-23-7 |
SB 415286,GSK3抑制剂 SB415286 |
98% |
|
|
阿拉丁 | S129720-50mg | 50mg | 现货 | 264218-23-7 |
SB 415286,GSK3抑制剂 SB415286 |
98% |
|
|
阿拉丁 | S129720-1mg | 1mg | 现货 | 264218-23-7 |
SB 415286,GSK3抑制剂 SB415286 |
98% |
|
|
阿拉丁 | S129720-5mg | 5mg | 现货 | 264218-23-7 |
SB 415286,GSK3抑制剂 SB415286 |
98% |
|
|
阿拉丁 | S407847-1ml | 1ml | 现货 | 264218-23-7 |
SB415286 SB415286 |
10mM in DMSO |
|
|
麦克林 | S873244-1mg | 1mg | 厂家现货 | 264218-23-7 |
SB415286 SB415286 |
99% |
|
|
毕得 | BD379906-10mg | 10mg | 现货 | 264218-23-7 |
3-((3-氯-4-羟基苯基)氨基)-4-(2-硝基苯基... 3-((3-Chloro-4-hydroxyphenyl... |
98% |
|
|
毕得 | BD379906-50mg | 50mg | 现货 | 264218-23-7 |
3-((3-氯-4-羟基苯基)氨基)-4-(2-硝基苯基... 3-((3-Chloro-4-hydroxyphenyl... |
98% |
|
|
毕得 | BD379906-100mg | 100mg | 现货 | 264218-23-7 |
3-((3-氯-4-羟基苯基)氨基)-4-(2-硝基苯基... 3-((3-Chloro-4-hydroxyphenyl... |
98% |
|
|
毕得 | BD379906-250mg | 250mg | 现货 | 264218-23-7 |
3-((3-氯-4-羟基苯基)氨基)-4-(2-硝基苯基... 3-((3-Chloro-4-hydroxyphenyl... |
98% |
|
|